VP, Head of Operations
Kal Lapan, Ph.D. is Vice President, Head of Operations at Psivant. She brings more than 20 years of entrepreneurial experience and a passion for building institutional capabilities that drive successful performance in early-stage biotech companies. She leads key general and administrative business functions focusing on R&D strategy, compliance, cross-functional alignment and scalable infrastructure. Kal is enthusiastic about cultivating collaborative environments and strategic partnerships to fuel biotech innovation.
Before joining Psivant, Kal held leadership positions in operations, program management and alliance management at Epizyme (acquired by Ipsen 2022), Mitobridge (acquired by Astellas in 2017), Magenta Therapeutics (Merged with Dianthus Therapeutics in 2023), Skyhawk Therapeutics, and Mitochondria Emotion. Throughout her career, she has guided teams in advancing multiple therapeutic candidates across various modalities and disease areas into the clinic.
Kal earned a Ph.D. in biochemistry and biophysics from the University of Rochester in Rochester, New York and a bachelor of arts degree in biology from Williams College in Williamstown, Massachusetts. She is a certified project manager and a Certified Strategic Alliance Professional (CSAP).